MCK

+ Watchlist + Portfolio

McKesson Corp.

Regulated industry Physical products Sells to businessesTags from an AI model reading the company description.

GridBrain — Sign in

GridSentinel — Sign in

GridAegis — Sign in

Key Metrics

Previous Close: $898.82
52-Week Range: $723.68 – $999.00
Market Cap: $105.20B
P/E (TTM): 24.18
EPS (TTM): 37.31
Dividend Yield: 0.42%

Advanced Metrics

Price/Book: —
PEG Ratio: 1.70
Return on Equity: —
Return on Assets: 4.74%
Gross Margin: 3.63%
Operating Margin: 1.35%
Profit Margin: 1.12%
Current Ratio: 0.89
Debt/Equity: —
Total Debt: $11.80B
Free Cash Flow: $6.80B
Revenue Growth: 7.70%
Earnings Growth: -17.60%
Enterprise Value: $114.77B

MCK Income statement, annual periods, in USD
USD	FY2023	FY2024	FY2025	FY2026
Revenue	$276.71B	$308.95B	$359.05B	$403.43B
Cost of Revenue	$264.35B	$296.12B	$345.73B	$388.88B
Gross Profit	$12.36B	$12.83B	$13.32B	$14.55B
Selling, General & Admin	$7.78B	$8.66B	$8.51B	$8.10B
Operating Expenses	$7.78B	$8.66B	$8.51B	$8.10B
Operating Income	$4.58B	$4.17B	$4.82B	$6.45B
EBITDA	$5.49B	$4.68B	$5.26B	$7.18B
Pretax Income	$4.63B	$3.79B	$4.36B	$6.20B
Income Tax	$905.00M	$629.00M	$878.00M	$1.10B
Net Income	$3.56B	$3.00B	$3.29B	$4.76B
Diluted EPS	25.03	22.39	25.72	38.38
Diluted Shares	142.20M	134.10M	128.10M	124.10M

MCK Balance Sheet statement, annual periods, in USD
USD	FY2023	FY2024	FY2025	FY2026
Cash & Equivalents	$4.68B	$4.58B	$5.69B	$3.98B
Receivables	$19.41B	$21.62B	$25.64B	$27.98B
Inventory	$19.69B	$21.14B	$23.00B	$24.21B
Current Assets	$44.29B	$47.97B	$55.40B	$57.21B
Total Assets	$62.32B	$67.44B	$75.14B	$82.32B
Current Liabilities	$47.96B	$52.36B	$61.60B	$67.02B
Long-Term Debt	$4.63B	$5.58B	$4.46B	$5.26B
Total Debt	$7.29B	$7.39B	$7.39B	$8.61B
Total Liabilities	$63.81B	$69.04B	$76.83B	$83.16B
Retained Earnings	$12.29B	$14.98B	$17.92B	$22.29B
Shareholders' Equity	-$1.86B	-$1.97B	-$2.07B	-$2.17B
Working Capital	-$3.67B	-$4.39B	-$6.21B	-$9.81B
Net Debt	$916.00M	$1.05B	—	$2.55B

MCK Cash Flow statement, annual periods, in USD
USD	FY2023	FY2024	FY2025	FY2026
Operating Cash Flow	$5.16B	$4.31B	$6.08B	$6.16B
Capital Expenditure	-$558.00M	-$687.00M	-$859.00M	-$745.00M
Free Cash Flow	$4.60B	$3.63B	$5.23B	$5.41B
Depreciation & Amortisation	$608.00M	$635.00M	$636.00M	$729.00M
Investing Cash Flow	-$542.00M	-$1.07B	-$733.00M	-$3.43B
Financing Cash Flow	-$4.37B	-$3.34B	-$3.96B	-$4.63B
Dividends Paid	-$292.00M	-$314.00M	-$345.00M	-$381.00M
Share Repurchases	-$3.64B	-$3.02B	-$3.15B	-$4.75B
Net Change in Cash	$719.00M	-$100.00M	$1.39B	-$1.91B

MCK Income statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Revenue	$90.82B	$97.83B	$103.15B	$106.16B	$96.30B	$105.38B
Cost of Revenue	$87.18B	$94.55B	$99.61B	$102.47B	$92.25B	$101.69B
Gross Profit	$3.64B	$3.28B	$3.54B	$3.69B	$4.04B	$3.69B
Selling, General & Admin	$1.98B	$2.20B	$2.07B	$2.03B	$1.80B	$2.26B
Operating Expenses	$1.98B	$2.20B	$2.07B	$2.03B	$1.80B	$2.26B
Operating Income	$1.66B	$1.08B	$1.47B	$1.66B	$2.25B	$1.42B
EBITDA	$1.71B	$1.26B	$1.66B	$1.88B	$2.38B	$1.58B
Pretax Income	$1.51B	$1.05B	$1.40B	$1.63B	$2.13B	$1.31B
Income Tax	$209.00M	$220.00M	$232.00M	$380.00M	$270.00M	$276.00M
Net Income	$1.26B	$784.00M	$1.11B	$1.19B	$1.68B	$614.00M
Diluted EPS	10.01	6.25	8.92	9.59	13.71	5.15
Diluted Shares	125.90M	125.50M	124.40M	123.70M	122.70M	119.20M

MCK Balance Sheet statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Cash & Equivalents	$5.69B	$2.42B	$4.00B	$2.96B	$3.98B	$5.16B
Receivables	$25.64B	$28.16B	$28.29B	$28.21B	$27.98B	$30.32B
Inventory	$23.00B	$25.07B	$26.13B	$27.07B	$24.21B	$26.26B
Current Assets	$55.40B	$56.80B	$59.89B	$59.70B	$57.21B	$62.84B
Total Assets	$75.14B	$81.31B	$84.16B	$84.19B	$82.32B	$88.33B
Current Liabilities	$61.60B	$64.33B	$68.03B	$68.13B	$67.02B	$70.36B
Long-Term Debt	$4.46B	$6.53B	$6.01B	$5.42B	$5.26B	$8.43B
Total Debt	$7.39B	$9.93B	$9.79B	$8.62B	$8.61B	$11.70B
Total Liabilities	$76.83B	$82.17B	$84.74B	$84.29B	$83.16B	$89.63B
Retained Earnings	$17.92B	$18.62B	$19.62B	$20.71B	$22.29B	$22.81B
Shareholders' Equity	-$2.07B	-$1.97B	-$1.74B	-$1.30B	-$2.17B	-$4.24B
Working Capital	-$6.21B	-$7.53B	-$8.14B	-$8.43B	-$9.81B	-$7.52B
Net Debt	—	$5.36B	$3.75B	$3.60B	$2.55B	$4.57B

MCK Cash Flow statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Operating Cash Flow	$7.75B	-$918.00M	$2.42B	$1.23B	$3.42B	-$220.00M
Capital Expenditure	-$278.00M	-$189.00M	-$196.00M	-$175.00M	-$185.00M	-$152.00M
Free Cash Flow	$7.47B	-$1.11B	$2.22B	$1.06B	$3.24B	-$372.00M
Depreciation & Amortisation	$151.00M	$157.00M	$188.00M	$188.00M	$196.00M	$195.00M
Investing Cash Flow	-$224.00M	-$3.56B	-$24.00M	-$269.00M	$425.00M	-$214.00M
Financing Cash Flow	-$2.85B	$1.18B	-$961.00M	-$2.03B	-$2.82B	$1.63B
Dividends Paid	-$91.00M	-$90.00M	-$89.00M	-$101.00M	-$101.00M	-$102.00M
Share Repurchases	-$300.00M	-$581.00M	-$818.00M	-$680.00M	-$2.67B	-$2.53B
Net Change in Cash	$4.67B	-$3.31B	$1.44B	-$1.06B	$1.03B	$1.20B

Market Snapshot

About

McKesson Corp. is a leading pharmaceutical distributor and healthcare technology company, providing supply chain management, data analytics, and software solutions to pharmacies and healthcare providers.